Pfizer Regenerative Medicine to work wth Athersys on stem cell therapies
CLEVELAND, Ohio — Ruth McKernan helped start Pfizer Regenerative Medicine — a research-oriented business unit of Pfizer, which calls itself the world’s largest research-based pharmaceutical company — in July 2008. “We see regenerative medicine — stem cell-based research and therapy — as an emerging area,” said McKernan, chief scientific officer for the regenerative medicine unit, during a …
[Read the full article here]Related News:
Pfizer signs license for stem cell research
Athersys still excited about Pfizer stem cell collaboration
Pfizer, University College London enter pact to develop stem cell-based therapies